Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionUMA Financial Services, Inc.
Latest Disclosed Ownership1,591 shares
Latest Disclosed Value $ 243,026
UMA Financial Services, Inc. reports 1.60% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 24, 2026 - UMA Financial Services, Inc. filed a 13F-HR form disclosing ownership of 1,591 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $204,444 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 1,566 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 1.60% during the quarter. The current value of the position is $192,511 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,591 25 1.60 243 13.02 0.0338
2026-01-29 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 1,566 24 1.56 216 9.14 0.0300
2025-11-04 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 1,542 1 0.06 198 5.91 0.0281
2025-07-14 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 1,541 85 5.84 186 14.81 0.0293
2025-07-11 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 1,541 186
2025-04-28 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,456 15 1.04 162 15.71 0.0279
2025-02-12 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 1,441 1,441 140 0.0237
2024-07-17 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 0 -2,204 -100.00 0 -100.00
2024-04-17 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,204 70 3.28 205 -11.26 0.0432
2024-01-23 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,134 0 0.00 231 11.06 0.0517
2023-10-10 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,134 0 0.00 208 -0.95 0.0536
2023-07-05 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,134 -652 -23.40 211 -23.08 0.0523
2023-04-20 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,786 -64 -2.25 273 4.20 0.0717
2023-01-25 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,850 -30 -1.04 262 17.49 0.0708
2022-10-06 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,880 0 0.00 223 -9.72 0.0685
2022-08-02 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,880 -149 -4.92 247 -7.49 0.0715
2022-05-05 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,029 -109 -3.47 267 -4.64 0.0709
2022-01-11 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,138 -517 -14.15 280 -8.20 0.0734
2021-10-19 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,655 -386 -9.55 305 -17.12 0.0839
2021-07-23 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 4,041 -9 -0.22 368 4.25 0.1054
2021-04-06 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 4,050 101 2.56 353 0.00 0.1149
2021-02-19 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,949 -213 -5.12 353 6.33 0.1201
2020-11-04 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 4,162 46 1.12 332 -2.06 0.1333
2020-08-11 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 4,116 90 2.24 339 -4.51 0.1366
2020-04-23 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 4,026 -50 -1.23 355 -7.07 0.1774
2020-01-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 4,076 213 5.51 382 8.22 0.1700
2019-11-26 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,863 3,863 353 0.1724
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.